ClinicalTrials.gg
RecruitingNCT07497464Updated Mar 27, 2026

Validity of an Open-access Handedness Recognition Task in Stroke Patients

An observational study in Stroke, sponsored by Alfredo Lerín Calvo. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Alfredo Lerín Calvo · Observational

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 323 studies in Stroke with a site in Spain — 73 open to participants now, 91 under way, 6 of them phase 3. Stroke · Spain.

Planned enrollment
73rd of 77
30 · median 250
Started
2025
with 28 others
Observational
77 of 323
16 open now
Primary completion
2026-11
later than 45 of 90 live
Registered
301st of 323
by date

Among the 323 studies in Stroke with a site in Spain, this one is the 73rd largest by planned enrollment of the 77 observational ones that give a count, is one of 29 that started in 2025, is one of 77 observational ones, reaches primary completion later than 45 of the 90 other live ones, and was the 301st registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

73 of the 323 studies in Stroke with a site in Spain are open now. Recruiting first, the newest first:

67 more — sign in →

All 73 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 323 studies in Stroke with a site in Spain, or all of them as a file.
02

Study summary

This study aims to assess the validity of a hand laterality discrimination task in patients who have suffered a stroke. The protocol involves two assessment sessions consisting of a Single Reaction Time (SRT) task and a Hand Laterality Judgement Task (HLJT). In the HLJT, participants are presented with images of right or left hands at various degrees of rotation and must determine the laterality of each hand. Primary outcomes include reaction time for the SRT, and both accuracy (percentage of correct responses) and decision-making time for the HLJT. Additionally, motor and kinesthetic imagery scales, as well as demographic and cognitive variables, are recorded.

Read the detailed description

The primary objective of this research is to evaluate the psychometric properties and validity of a hand laterality discrimination task in a post-stroke population. The study design includes two identical measurement points to assess the reliability and accuracy of motor processing.

The experimental protocol is divided into two main components:

Single Reaction Time (SRT) Task: This task is used to establish a motor processing baseline by measuring the simple reaction time to a stimulus.

Hand Laterality Judgement Task (HLJT): A mental rotation task where patients are shown photographs of right and left hands at different angles of rotation. Participants must decide whether the hand shown is a right or a left hand. The variables analyzed are the accuracy rate (percentage of correct responses) and the decision-making time (latency).

Upon completion of the HLJT, a structured interview is conducted to identify the mental strategies used during the task. This allows researchers to determine whether patients relied on motor imagery (e.g., mentally moving their own hand) or external visual strategies to achieve the results.

To complement these data, the study incorporates validated motor and kinesthetic imagery scales to assess the subjective quality of movement representation. Furthermore, demographic data (such as age and time since stroke) and cognitive variables are collected to control for potential confounding factors that may influence performance on the laterality tasks.

To evaluate the changes and the validity of the measurements, an Analysis of Covariance (ANCOVA) will be performed. In this model, the baseline measurement (Session 1) will be included as a covariate to control for initial individual differences in reaction time and accuracy. This approach allows for a more precise estimation of the task's stability and the effect of the variables studied by reducing the error variance associated with the participants' starting scores.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Hand laterality judgement task
  • Tool validation
  • Laterality judgement
  • Stroke patients laterality judgement ability
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult stroke survivors who have experienced a cerebrovascular accident. To ensure participants can understand the task instructions and provide reliable data, a cognitive screening is performed. Only individuals with a Montreal Cognitive Assessment (MoCA) score of greater than 21 ($MoCA > 21$) are included, thereby excluding patients with severe cognitive impairment that could interfere with the mental rotation and imagery tasks

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (>18 years old) with Stroke
  • score > 21 points

Exclusion criteria

Exclusion Criteria:

  • Other neurological conditions
  • Severe cognitive impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke group

    This is a single-group study involving a cohort of stroke patients. All participants will undergo the same assessment protocol, including the Single Reaction Time (SRT) task, the Hand Laterality Judgement Task (HLJT) with post-task strategy interviews, and the administration of motor imagery, demographic, and cognitive scales.

06

What researchers measure

Primary outcomes

  1. Hand Laterality Judgement

    Ability to disclosure right/left hand laterality

    Time frame: At baseline + a follow-up 1 week later

  2. Single Reaction Time Task

    Time frame: At baseline + a follow-up 1 week later

07

Study locations

1 of 1 sites recruiting
  • Neuron Clinics
    Madrid, Madrid, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All used databases (anonymized data) will be uploaded to zenodo

Supporting information: Study protocol, Informed consent form

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Nov 2026, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2026
First posted
Mar 27, 2026
StartActual
Oct 7, 2025
Primary completionEst.
Nov 2026
CompletionEst.
May 2027
Last update
Mar 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07497464
Lead sponsor
Alfredo Lerín Calvo
Collaborators
KU Leuven
Responsible party
Alfredo Lerín Calvo (Physical therapist, Neuron, Spain) — Sponsor-investigator
First posted
Mar 27, 2026
Start date
Oct 7, 2025
Primary completion
Nov 2026 (estimated)
Completion
May 2027 (estimated)
Last update
Mar 27, 2026

Study contacts

Marcos Moreno Verdú, Physical Therapist
Contact
marcos.morenoverdu@uclouvain.be
+34 630 01 29 25
Alfredo Lerín Calvo, Physical Therapist
Contact
alerin@neuronrehab.es
+34 620187457

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion